NHS England stated that legal and operational responsibility for deploying and operating the Oxevision camera system rests entirely with individual NHS foundation trusts.

Overview Debates Related claims Topics Sources

India's Ministry of Health launched the Strategy for Artificial Intelligence in Healthcare for India in February 2026 to govern data, validation, deployment, and monitoring.

India's Central Drugs Standard Control Organisation issued guidance in July 2026 establishing approval pathways for Software in a Medical Device and Software as a Medical Device.

Regulatory sandboxes allow health authorities to evaluate rapidly evolving artificial intelligence technologies and balance patient safety against clinical innovation.

A joint report by European science academies proposed regulatory sandboxes as controlled, time-limited environments to test medical artificial intelligence tools under regulatory oversight before clinical deployment.

Sound Practice 10 of the Financial Stability Board's guidance establishes a risk-based intervention model requiring mandatory human sign-off for financial transactions exceeding specific thresholds.

The Financial Stability Board published 12 non-binding recommended practices on October 16, 2026, for the responsible adoption of artificial intelligence in financial institutions across G20 economies.

Bank of England Governor Andrew Bailey proposed pre- and post-deployment testing protocols for frontier AI models used in finance and G20-level agreements governing access to foreign-built frontier models.

The OCC, Federal Reserve Board, and FDIC plan a future request for information regarding bank AI model risk management, though no timeline has been set.

The American Medical Association's framework focuses on four questions covering clinical functions, evidence of performance, conditions of permission, and risk accountability.

The Financial Stability Board declined to framing AI systems as synthetic employees, citing concerns that the analogy obscures unpredictable autonomous decisions.

Updated Sound Practice 12 requires financial institutions to perform due diligence and maintain ongoing oversight of embedded AI functionality extending to fourth- and nth-party vendors.

The American Medical Association released a new governance framework on October 15, 2026, to guide the safe deployment of agentic AI assuming clinical functions in healthcare.

Moody's warned in August 2026 that banks deploying AI risk systemic dependency on concentrated technology providers, specifically naming OpenAI and Anthropic.

In a survey of 250 U.S. healthcare leaders, 28% reported deploying agentic AI tools and 72% reported that agentic AI is occasionally implemented without IT approval.

To address legal ambiguities, the Office of Artificial Intelligence Policy requires a special malpractice insurance covering AI-generated prescriptions and builds specific duty of care provisions into contracts.

The Nolla Health pilot was amended to include a third-party physician appointed by the Utah Medical Licensing Board to oversee prescription reviews.

Stanford University professor Michelle Mello argued in a JAMA Health Forum commentary that Doctronic's contract is legally murky regarding liability for potential AI-based prescribing errors.

Doctors commit malpractice if they diagnose patients without consulting artificial intelligence

Dr. Beau Bailey of Intermountain Health emphasized that using AI without sufficient oversight and protocols poses direct risks to patient safety and operational costs.

Intermountain Health is taking a cautious approach to AI implementation to mitigate potential risks to patient safety.